What does CUSIP 89853L104 represent in this 13F holders report?

CUSIP 89853L104 is the security identifier for TTOO - T2 BIOSYSTEMS INC - COM used to aggregate holder disclosures.

How many institutions held TTOO - T2 BIOSYSTEMS INC - COM in Q3 2014?

40 institutional investors reported TTOO - T2 BIOSYSTEMS INC - COM for Q3 2014. Use the holders table for investor-level position and value details.

T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class: Equity / COM
Total 13F shares: 9,985,277
Share change: +9,984,667
Total reported value: $180,634,000
Price per share: $18.09
Number of holders: 40
Value change: +$180,623,000
Number of buys: 39

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2014

Recent filing periods for CUSIP 89853L104:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q3 2014

As of 30 Sep 2014, T2 BIOSYSTEMS INC - COM (TTOO) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,985,277 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, Polaris Venture Management Co. V, L.L.C., GILDER GAGNON HOWE & CO LLC, FMR LLC, WELLINGTON MANAGEMENT CO LLP, Harvest Capital Strategies LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, BlackRock Fund Advisors, RA CAPITAL MANAGEMENT, LLC, and VANGUARD GROUP INC. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.